All podcasts

Gene Writing: New Tech to Correct Disease

Gene editing is a relatively new technology that has revolutionary applications in agriculture and medicine.  The drawback to the technology is that it typically can only be used to disrupt a deleterious gene underlying a specific trait.  Gene writing exploits a natural process in cells that allows researchers to install genes of interest, allowing replacement of damaged sequences that lead to negative health outcomes.  Dr. Geoff von Maltzahn of Tessera describes what the new technology is and its most likely applications, particularly in the area of correcting genetic disease.

Nov 14, 2020 by Dr. Kevin Folta in Talking Biotech

Apple podcasts link Google podcasts link Spotify podcasts link

Gene editing is a relatively new technology that has revolutionary applications in agriculture and medicine. The drawback to the technology is that it typically can only be used to disrupt a deleterious gene underlying a specific trait. Gene writing exploits a natural process in cells that allows researchers to install genes of interest, allowing replacement of damaged sequences that lead to negative health outcomes. Dr. Geoff von Maltzahn of Tessera describes what the new technology is and its most likely applications, particularly in the area of correcting genetic disease. Twitter: Tessera @TesseraTx Dr. Geoffrey von Maltzahn; @GVMaltzahn # COLABRA Talking Biotech is brought to you by Colabra – an R&D platform that brings your lab’s world-changing research together in one shared space. Learn more at https://www.colabra.app/ # TALKING BIOTECH Twitter: https://twitter.com/talkingbiotech Website: https://www.colabra.app/podcasts/talking-biotech/ Instagram: https://www.instagram.com/colabrahq The Talking Biotech podcast is distinct from Dr. Kevin Folta's teaching and research roles at the University of Florida. The views expressed on the show are those of Dr. Folta and his guests, and do not reflect the opinions of the university or Colabra.

Colabra

Get your whole lab on the same page today.

Learn more